SAO PAULO (Reuters) – The National Health Surveillance Agency (Anvisa) on Saturday determined the precautionary ban on batches of Chinese vaccine against Covid-19 CoronaVac, prohibiting the distribution and use of batches in a plant not approved in the emergency use authorization , said the regulator in a statement.
According to the statement, Anvisa was informed the day before by the Butantan Institute that Sinovac, the manufacturer of CoronaVac, sent to Brazil 25 batches in the vial-ampoule presentation (single dose and two doses), totaling 12,113,934 doses.
Read Also
- How are the new Mini LED TVs with 8K resolution: everything that was presented at IFA 2021 Sep 8, 2021
- Petro defended himself against the accusations of having kidnapped Pacheco: “I only saw him on television” May 31, 2022
- Home office: the 5 essential devices to work from home Sep 1, 2021
- Ibai will broadcast Messi’s debut with Paris Saint-Germain on Twitch Aug 25, 2021
- In Teglio excursions on foot or by bike in the less known Valtellina Jul 10, 2021
- Banreservas Fair finances more than RD$7,000 million May 23, 2022
- Maine-et-Loire: Sentenced after threatening his partner with death with a chainsaw Nov 15, 2022